Back to Home
Free On-DemandOn-Demand Webinar

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Release Date

November 10, 2025

Expiration Date

November 11, 2026

Credits

1.0 On-Demand

Topics

Lung Cancer, Oncology

This webinar is part 3 in a 3-part curriculum.

Program Description

The management of non-small cell lung cancer (NSCLC) has evolved significantly with the integration of precision medicine. This approach allows for the selection of therapies based on a patient's specific tumor characteristics, which can lead to improved survival outcomes and greater treatment efficacy. For oncology pharmacists, being knowledgeable about this topic is crucial, as they play a central role in interpreting these test results and applying them to treatment and management decisions. This 3-part continuing education program, "Precision in Practice for Oncology Pharmacists: Exploring Opportunities to Ensure Accuracy in Non-Small Cell Lung Cancer Treatment," is designed to equip oncology pharmacists with the knowledge and skills necessary to navigate this evolving field and play a central role in delivering precision care in NSCLC. The series consists of 2 webinars and a multidisciplinary panel discussion exploring the current state of precision medicine in NSCLC, detailing its methodologies, clinical applications, and practical implementation for oncology pharmacists. Explore each of these activities to advance your knowledge and skills in precision medicine for NSCLC, and learn how to apply these concepts to improve patient care within your own practice.

Target Audience: Oncology Pharmacist

Type of Activity: Application
Release date: November 10, 2025
Expiration date: November 10, 2026
Learner level: Intermediate
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Document the unique and shared barriers to optimal biomarker testing across academic institutions and community-based environments
  • Identify pharmacist-led interventions to improve biomarker testing practices in non-small cell lung cancer
  • Exercise best practices that have optimized biomarker testing workflows in NSCLC
Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

This activity is supported by independent medical educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. and Lilly.

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Related Content

Course

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Create Account